Menlo and a16z back AI scientist startup Phylonews2026-02-03T12:00:21+00:00February 3rd, 2026|Endpoints News|
Carbon Health files for bankruptcy, seeking to sell or restructurenews2026-02-02T21:22:13+00:00February 2nd, 2026|Endpoints News|
First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?news2026-02-02T20:42:11+00:00February 2nd, 2026|Endpoints News|
New CagriSema data show improvement over semaglutidenews2026-02-02T19:16:29+00:00February 2nd, 2026|Endpoints News|
GSK returns rights to Wave’s RNA editing program for AATDnews2026-02-02T16:06:46+00:00February 2nd, 2026|Endpoints News|
Spring Health acquires Alma, expanding insurance reach in virtual mental healthnews2026-02-02T15:43:15+00:00February 2nd, 2026|Endpoints News|
Kyowa Kirin reveals side effect in trial; GSK was lone bidder for RAPTnews2026-02-02T15:22:27+00:00February 2nd, 2026|Endpoints News|
FDA rejects Aquestive’s allergy drug over packaging issuesnews2026-02-02T15:17:06+00:00February 2nd, 2026|Endpoints News|
FDA opens submissions for PreCheck program to speed up US factory buildsnews2026-02-02T14:46:33+00:00February 2nd, 2026|Endpoints News|
SanegeneBio licenses RNAi candidate to Genentech for $200M upfrontnews2026-02-02T14:35:38+00:00February 2nd, 2026|Endpoints News|
